Research demonstrates the synthesis of 1,2,4-triazinyl furazans in various conditions, suggesting potential pharmacological applications.
The interaction of (3-methylfurazanyl)- and (3-aminofurazanyl)amidrazones with 1,2-dicarbonyl compounds (ninhydrin, glyoxal and benzyl) was studied. It was shown that upon using glyoxal, only acyclic products of dimeric structure were formed, while the introduction of other studied 1,2-dicarbonyl compounds into the reaction led to the target (1,2,4-triazin-3-yl)furazans. The structure of the obtained products was confirmed by IR and NMR spectroscopy and X-ray structural analysis. The synthesized biheterocyclic structures are of interest as a platform for the design of pharmacologically active compounds with different spectra of action.
No takes yet. Share an insight, caveat, or question.
A.A. Larin (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: